Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: Heidelberg Pharma AG
Condition: Advanced Solid Tumours
NCT01581060
Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
Study terminated for business reasons